DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Barrueco J, Marshall J, Mitchell E et al.
Safety and efficacy of first-line irinotecan/fluoropymidine combinations in mCRC patients >65 years compared with those <65: The BICC-C study.
Journal of Clinical Oncology 2007; ASCO Annual Meeting Proceedings Part I 2007;
25 (Suppl. 18) Abstract 4076
We do not assume any responsibility for the contents of the web pages of other providers.